InVivo Therapeutics Holdings buy BiotechBee
Start price
10.01.23
/
50%
€2.16
Target price
31.12.25
€4.00
Performance (%)
-46.57%
End price
05.05.23
€1.15
Summary
This prediction ended on 05.05.23 with a price of €1.15. Massive losses of -46.57% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
InVivo Therapeutics Holdings | 3.145% | 3.145% | -71.278% |
iShares Core DAX® | -0.992% | -3.231% | 11.661% |
iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
iShares S&P 500 | -0.509% | -2.979% | 26.341% |
According to BiotechBee what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Invivo Therapeutics diskutieren
Buy mit Kursziel 4,0
In the thread Trading InVivo Therapeutics Holdings
Buy beendet